What happens when a skin cancer diagnosis goes beyond the dermatologist's office?
In this episode of Skinside Out, Dr. Zain Husain is joined by two leading medical oncologists to discuss advanced squamous cell carcinoma, melanoma, immunotherapy, clinical trials, and the future of cancer treatment. The conversation explores how dermatologists, surgeons, radiation oncologists, and medical oncologists work together to create personalized treatment plans for patients with complex skin cancers.
The team explains how melanoma spreads, the role of sentinel lymph node biopsies, why immunotherapy has transformed cancer care, and the promising new therapies being developed through clinical research. They also share their perspectives on the future of cancer treatment and whether cancer may someday become a manageable chronic disease rather than a terminal diagnosis.
Whether you're a patient, caregiver, healthcare professional, or simply interested in the latest advances in cancer care, this episode provides an informative look at the rapidly evolving world of oncology.
Learn more about Noor Dermatology:
https://www.noorderm.com/
Timestamps
00:00 – Introduction and guest introductions
00:40 – Meet the medical oncologists and their backgrounds
02:00 – How dermatologists and oncologists work together
03:00 – When skin cancer requires advanced treatment
04:00 – The multidisciplinary approach to skin cancer care
06:00 – How treatment decisions are made for complex cases
08:00 – Understanding advanced squamous cell carcinoma
09:00 – Features that make squamous cell carcinoma high-risk
10:00 – Tumor size, location, and recurrence risk
11:00 – Pathology findings that influence treatment
12:00 – Risk classification systems for squamous cell carcinoma
14:00 – Treatment options for advanced squamous cell cancer
15:00 – How immunotherapy works
16:00 – Why immunotherapy changed cancer treatment forever
17:00 – Organ transplant patients and skin cancer risk
18:00 – Jimmy Carter, melanoma, and the impact of immunotherapy
19:00 – Neoadjuvant immunotherapy and treatment before surgery
20:00 – Why timing matters in melanoma treatment
20:30 – Key pathology findings in melanoma
22:00 – Melanoma staging and depth of invasion
22:30 – What is a sentinel lymph node biopsy?
24:00 – How melanoma spreads through the lymphatic system
25:00 – Why sentinel lymph node biopsies matter
26:00 – Benefits and limitations of lymph node evaluation
27:00 – Comparing melanoma and squamous cell treatment approaches
29:00 – The future of skin cancer therapies
30:00 – EGFR inhibitors and emerging treatments
31:00 – Injectable immunotherapy and localized treatments
32:00 – Melanoma vaccines and personalized cancer treatment
33:00 – New clinical trial results and cancer research
34:00 – Current clinical trials at Duke
35:00 – New approaches to immune therapy
36:00 – Genomic sequencing and targeted therapies
37:00 – BRAF mutations and precision medicine
38:00 – Gene expression profiling and cancer risk assessment
39:00 – Will we cure cancer in our lifetime?
40:00 – Recent breakthroughs in pancreatic cancer research
41:00 – Why cancer is actually hundreds of diseases
42:00 – Cancer as an evolving biological opponent
43:00 – The future of cancer as a chronic disease
44:00 – Hope, innovation, and improving quality of life
45:00 – Final thoughts and closing remarks